An All-in-One Approach for Small-Volume Cell Processing from Washing to Final Formulation, Fill, and Finish
28 April 2023
This Presentation from Advanced Therapies Week 2023 focusses on an all-in-one approach for small-volume cell processing from washing to final formulation, fill, and finish.
During this session, Alaina Schlinker, Senior Manager in the Field Application Support Team at ScaleReady, explores Cue – a small volume cell processing system.
The Cue Cell Processing System is for laboratory use only and may not be used for direct transfusion. Appropriate regulatory clearance is required by the user for clinical use.
Refer to the Cue Cell Processing System User’s Guide for a complete list of warnings and precautions associated with the use of this device.
This Presentation was presented at Advanced Therapies Week 2023, in partnership with ScaleReady.
More like this
Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer
Eureka Therapeutics has received a $10.6 million grant from the California Institute for Regenerative Medicine (CIRM) to support its ongoing ARYA-2 Phase I study of ET140203 for the treatment of refractory/relapsed liver cancer for pediatric patients.
8 June 2023
Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities
UK-based independent innovation and technology organization Cell and Gene Therapy Catapult (CGT Catapult), has officially opened new laboratories and offices in Edinburgh, Scotland, UK, BioQuarter – enhancing Edinburgh’s role as a hub for cell therapies.
7 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™ Advanced Therapy Platform at the 29th International Society for Cell & Gene Therapy (ISCT) annual event with proven assets and expertise to help early-stage biotech companies effectively deliver to patients without compromising quality.
5 June 2023